Literature DB >> 23098415

Indicators of benzodiazepine use in nursing home residents in France: a cross-sectional study.

Philipe de Souto Barreto1, Maryse Lapeyre-Mestre, Céline Mathieu, Christine Piau, Catherine Bouget, Françoise Cayla, Bruno Vellas, Yves Rolland.   

Abstract

OBJECTIVES: Little information is available about associations between nursing home (NH) structural and organizational aspects and benzodiazepine prescriptions, particularly for long-acting drugs. This study addressed this knowledge gap.
DESIGN: Cross-sectional study.
SETTING: One hundred seventy-five NHs from France. PARTICIPANTS: A total of 6275 NH residents, aged 86 years (± 8.2), and mostly women (73.7%). MEASUREMENTS: Outcome measures were: (1) benzodiazepine and (2) long-acting benzodiazepine use. NH staff sent to research team all drug prescriptions in the week participants were included in the study; staff also recorded information on residents' characteristics, and NHs structure and internal organization. Binary logistic regressions were performed separately on total and long-acting benzodiazepine.
RESULTS: A total of 3350 persons took benzodiazepine; 577 took long-acting benzodiazepine. Subject-related characteristics were the main correlates of benzodiazepine use. NH characteristics were also related to this outcome: number of beds ≥ 91 (Odds Ratio (OR) 0.820, 95% Confidence Interval (CI) 0.682-0.986), special care unit (OR 1.131, 95% CI 1.000-1.279), pharmacy for internal usage (OR 1.341, 95%CI 1.128-1.594), and date records of the first prescription of psychotropics (OR 1.394, 95% CI 1.209-1.607). Pharmacy for internal usage was also associated with long-acting benzodiazepine (OR 1.374, 95% CI 1.076-1.754).
CONCLUSIONS: NH structure- and organization-related indicators impact benzodiazepine use among NH residents. This finding is of particular importance because these indicators are more easily modifiable than subject-related characteristics. Therefore, NH directors and medical staff should be aware about this to implement feasible modifications for reducing inappropriate and chronic benzodiazepine use.
Copyright © 2013 American Medical Directors Association, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23098415     DOI: 10.1016/j.jamda.2012.09.002

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  10 in total

1.  The nursing home population: an opportunity to make advances on research on multimorbidity and polypharmacy.

Authors:  P de Souto Barreto; B Vellas; J E Morley; Y Rolland
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

2.  The use of an electronic clinical rule to discontinue chronically used benzodiazepines and related Z drugs.

Authors:  C Mestres Gonzalvo; V Milosevic; B P C van Oijen; H A J M de Wit; K P G M Hurkens; W J Mulder; R Janknegt; J M G A Schols; F R Verhey; B Winkens; P H M van der Kuy
Journal:  Eur J Clin Pharmacol       Date:  2017-11-10       Impact factor: 2.953

3.  Reducing potentially inappropriate drug prescribing in nursing home residents: effectiveness of a geriatric intervention.

Authors:  Charlène Cool; Philippe Cestac; Cécile McCambridge; Laure Rouch; Philipe de Souto Barreto; Yves Rolland; Maryse Lapeyre-Mestre
Journal:  Br J Clin Pharmacol       Date:  2018-05-14       Impact factor: 4.335

Review 4.  A Review of Adverse Outcomes Associated with Psychoactive Drug Use in Nursing Home Residents with Dementia.

Authors:  Maryse Lapeyre-Mestre
Journal:  Drugs Aging       Date:  2016-12       Impact factor: 3.923

5.  Feasibility of discontinuing chronic benzodiazepine use in nursing home residents: a pilot study.

Authors:  Jolyce Bourgeois; Monique M Elseviers; Luc Van Bortel; Mirko Petrovic; Robert H Vander Stichele
Journal:  Eur J Clin Pharmacol       Date:  2014-08-08       Impact factor: 2.953

6.  Effects of a geriatric intervention aiming to improve quality care in nursing homes on benzodiazepine use and discontinuation.

Authors:  Philipe de Souto Barreto; Maryse Lapeyre-Mestre; Philippe Cestac; Bruno Vellas; Yves Rolland
Journal:  Br J Clin Pharmacol       Date:  2016-01-08       Impact factor: 4.335

7.  Health status and drug use 1 year before and 1 year after skilled nursing home admission during the first quarter of 2013 in France: a study based on the French National Health Insurance Information System.

Authors:  Alice Atramont; Dominique Bonnet-Zamponi; Isabelle Bourdel-Marchasson; Isabelle Tangre; Anne Fagot-Campagna; Philippe Tuppin
Journal:  Eur J Clin Pharmacol       Date:  2017-10-03       Impact factor: 2.953

8.  Use of Central Nervous System (CNS) Medicines in Aged Care Homes: A Systematic Review and Meta-Analysis.

Authors:  Syed Shahzad Hasan; Syed Tabish Razi Zaidi; Jorabar Singh Nirwan; Muhammad Usman Ghori; Farideh Javid; Keivan Ahmadi; Zaheer-Ud-Din Babar
Journal:  J Clin Med       Date:  2019-08-23       Impact factor: 4.241

9.  Geriatric Depression and Inappropriate Medication: Benefits of Interprofessional Team Cooperation in Nursing Homes.

Authors:  Hana Vankova; Iva Holmerova; Ladislav Volicer
Journal:  Int J Environ Res Public Health       Date:  2021-11-26       Impact factor: 3.390

10.  Potentially inappropriate medications in elderly ambulatory and institutionalized patients: an observational study.

Authors:  Daniela Petruta Primejdie; Marius Traian Bojita; Adina Popa
Journal:  BMC Pharmacol Toxicol       Date:  2016-08-21       Impact factor: 2.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.